Indeed, there are numerous disease states in which NRF2 activation and NLRP3 inhibition are known to be beneficial including neurodegenerative diseases, metabolic diseases, gastrointestinal diseases, and autoimmune disorders. The gene discussed is NFE2L2; the disease is gastrointestinal disease.